Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

MYnd Analytics’ Peer Report Featured on CBS New York

MYnd Analytics,Inc.a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence,announced that the Company’s Psychiatric EEG Evaluation Registry (“PEER”) was featured on CBS New York by medical correspondent Dr. Max Gomez.

Commenting on the news story, George Carpenter, CEO of MYnd stated, “We appreciate Jan Petty for coming forward with an inspiring story that gives hope to others suffering with depression, and we’re grateful to the thousands of people like Jan who have contributed their own outcomes to the science of reducing trial and error in mental health.”

Read More: Palo Alto Networks Appoints Amit K. Singh as President

Related Posts
1 of 3,105

MYnd Analytics, Inc.is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. The Company’s Psychiatric EEG Evaluation Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the Company’s original physician-developed database, there are now more than 40,000 outcomes for over 11,000 unique patients in the PEER registry. The goal of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications.

Read More: Interview with Angel Gambino, CEO and Founder of Sensai

MYnd also operates its wholly owned subsidiarity Arcadian Telepsychiatry Services, LLC which manages a suite of services including telepsychiatry, teletherapy, digital patient screening, curbside consultation, on-demand services, and scheduled encounters for all age groups. Arcadian utilizes patient engagement and re-engagement strategies so that care is effectively completed, helping to comfortably move inpatient care to outpatient, assisting patients in readjusting to their life routine, as well as reducing wait times for mental health treatment. Arcadian’s customer base includes major health plans, health systems, and community-based organizations.

Read More: Interview with Ben Goertzel, CEO at SingularityNET

Leave A Reply

Your email address will not be published.